Exosomes as a tumor immune escape mechanism: possible therapeutic implications
2008

Exosomes and Cancer Immune Suppression

Sample size: 16 publication Evidence: moderate

Author Information

Author(s): Ichim Thomas E, Zhong Zhaohui, Kaushal Shalesh, Zheng Xiufen, Ren Xiubao, Hao Xishan, Joyce James A, Hanley Harold H, Riordan Neil H, Koropatnick James, Bogin Vladimir, Minev Boris R, Min Wei-Ping, Tullis Richard H

Primary Institution: Medistem Laboratories Inc, San Diego, USA

Hypothesis

Can exosomes secreted by cancer cells contribute to immune suppression and affect cancer therapy outcomes?

Conclusion

The study suggests that exosomes play a significant role in tumor immune evasion and proposes a novel therapeutic approach to remove these exosomes to enhance immune response against cancer.

Supporting Evidence

  • Exosomes from cancer cells can express immune suppressive molecules.
  • High concentrations of exosomes in cancer patients are linked to T cell apoptosis.
  • Extracorporeal removal of exosomes may enhance immune response in cancer patients.

Takeaway

Cancer cells can release tiny bubbles called exosomes that help them hide from the immune system, making it harder for the body to fight the cancer. Researchers are looking at ways to remove these exosomes to help the immune system work better.

Methodology

The study discusses the role of exosomes in immune suppression and explores the use of extracorporeal filtration to remove these exosomes from cancer patients.

Limitations

The approach may not selectively target specific inhibitors and could result in the loss of immune stimulatory cytokines.

Participant Demographics

Patients with metastatic cancers were involved in the study.

Digital Object Identifier (DOI)

10.1186/1479-5876-6-37

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication